
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.

Hims & Hers' rally is fueled by branded weight-loss growth, international expansion, AI efficiencies and a broader specialty portfolio.

ADP's 13.4% monthly gain reflects stronger profitability, innovation initiatives, solid liquidity and a consistent commitment to shareholder returns.

AI data centers need a lot of power, which is straining electrical infrastructure. Changes are coming that benefit two makers of electrical equipment. On Thursday, Baird analyst Luke Junk launched coverage of Eaton and Hubbell Eaton makes power and thermal management products for AI data centers and other commercial and utility customers.

Walmart's (WMT) mixed second-quarter performance has raised questions around the trajectory of its c

This year, the biotech stock has underperformed both the Nasdaq Biotechnology Index and the S&P 500.

Three Dividend Kings with 50-plus years of raises could pay you for decades.

Critical minerals stocks are surging while the broader market barely twitches, and the forces driving the move have less to do with company news than with a shift happening deep inside the bond market and the dollar.

The stock market is about to break a record. It's not a record it wants to break.

His Duquesne Family Office opened a position in Reddit in the second quarter.

UBS Global Wealth Management, part of UBS Group AG (NYSE:UBS), expects the S&P 500 as measured by the State Street SPDR S&P 500 ETF Trust (NASDAQ:SPY) to finish 2026 at 8,100, roughly 6% above Thursday’s close of 7,641. Prediction market...

The mRNA trade is whipsawing for a third straight session as the market keeps repricing a single trial readout with no fresh clinical information hitting the tape Friday. Friday’s swing is happening while the broader market barely moves, with the S&P 500 up 0.3% and the NASDAQ 100 up 0.1%. That backdrop shows the volatility ... Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session

Consumer discretionary businesses are levered to the highs and lows of economic cycles. Unfortunately, the industry’s recent performance suggests demand may be slowing as discretionary stocks’ 6.3% return over the past six months has trailed the S&P 500 by 6.4 percentage points.

Shares of the Bitcoin investor have soared this week, putting them on course for their best three-day stretch since November 2024.

Bitcoin's sharp breakout is sending shockwaves through retail brokerage stocks, but Robinhood and Webull are catching the move in very different ways, and the gap between them reveals something important about how each company is actually built.

Aug 21 (Reuters) - Wall Street's main indexes opened higher on Friday after getting hammered in the previous session, though markets remained on track to end the week in the red as surging government

Bitcoin outran stocks 140x this week, then stalled at $79,500. Three resistance layers now block the road to $80,000.

S&P 500 companies are delivering strong second-quarter results, with Wolfe Research pointing to widespread revenue beats, upbeat guidance and an unusually robust earnings growth outlook for 2026. According to the research firm, 465 companies in the S&P 500 had reported their second-quarter 2026 results through Wednesday.

While most investors chase flashy tech names, a quiet group of blue-chip dividend payers is staging a stunning run in 2026 that even the S&P 500 cannot match. The companies behind these gains may surprise you.

Protecting yourself from a bear market isn't about just shifting your portfolio into cash.

DZ Bank analyst Markus Leistner launches coverage of SpaceX stock with a Sell rating and $100 price target.

The AI powerhouse will give investors a major update next week.

Goldman strategists said July marked one of the sharpest hedge fund de-grossing episodes of the past decade
Nvidia investors want something new.

Tesla stock rose early Friday, trying to close out a solid week on a high note. An electric vehicle is helping, which is a surprise for the EV maker these days. The move comes as Tesla announced a launch event for its all-electric semi truck for Europe.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.